@inproceedings{inproceedings, title  = {{Abstract P4-04-06: AZD5363, an AKT inhibitor, significantly inhibits key biomarkers of the AKT pathway and Ki67, in a randomized, placebo, controlled study (STAKT) in human breast cancers}},

 publisher = {{American Association for Cancer Research}},

 url = {{}},

 year = {{2018}},

 month = {{2}},

 author = {{Robertson JFR and Coleman RE and Cheung KL and Evans A and Holcombe C and Skene A and Rea D and Ahmed S and Jahan A and Kelly S and Horgan K et al}},

 doi = {{10.1158/1538-7445.sabcs17-p4-04-06}},

 journal = {{Poster Session Abstracts}},

 note = {{Accessed on 2025/10/10}}}